Skin Anergy Testing and Tuberculosis Surveillance
Authors:
- 1 October 1997
- journal article
- research article
- Published by SAGE Publications in Journal of Correctional Health Care
- Vol. 4 (2) , 139-153
Abstract
Our objective was to assess the utility of the addition of delayed latent type hypersensitivity antigens (anergy testing) to purified protein derivative (PPD) tuberculin skin testing on intake to a correctional facility. We conducted a retrospective review of a two and a half year period during which new inmates were skin tested with PPD, Candida albicans, and mumps antigens by the Mantoux method. Of the 11,514 tested, 7.0 percent had prior PPD positive test results, 4.2 percent were new PPD positive, and 6.6 percent were anergic. HIV prevalence was 6 percent. Three active cases of tuberculosis were found. No benefit from anergy skin testing was found in this jail population.Keywords
This publication has 20 references indexed in Scilit:
- Incidence of Tuberculosis in the United States among HIV-Infected PersonsAnnals of Internal Medicine, 1997
- Miliary TuberculosisChest, 1996
- Reliability of Anergy Skin Testing in Persons With HIV Infection. The Pulmonary Complications of HIV Infection Study GroupAmerican Journal of Respiratory and Critical Care Medicine, 1996
- In Vitro T Cell Function, Delayed-Type Hypersensitivity Skin Testing, and CD4+ T Cell Subset Phenotyping Independently Predict Survival Time in Patients Infected with Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1995
- Transmission of Tuberculosis in New York City -- An Analysis by DNA Fingerprinting and Conventional Epidemiologic MethodsNew England Journal of Medicine, 1994
- The Tuberculin Skin TestClinical Infectious Diseases, 1993
- Risk for Developing Tuberculosis among Anergic Patients Infected with HIVAnnals of Internal Medicine, 1993
- Abnormal chest x-rays in intravenous drug users: implications for tuberculosis screening programs.American Journal of Public Health, 1993
- Medical Section of the American Lung Association: Control of Tuberculosis in the United StatesAmerican Review of Respiratory Disease, 1992
- Isoniazid as Preventive Therapy in HIV-Infected Intravenous Drug AbusersJAMA, 1991